Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Sales & Marketing
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — sales & marketing of $789K in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing decreased by 4.9% year-over-year, from $830K to $789K.
- What does cygnus — sales & marketing mean?
- Includes all expenses related to the promotion, advertising, and sales force activities dedicated to the Biologics Safety Testing segment. This metric measures the investment required to acquire and retain customers in the competitive life sciences market. It is essential for assessing the segment's customer acquisition cost and market expansion strategy.